54 results
Page 2 of 3
8-K
EX-99.2
2814czyofno3nbgc2
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
8-K
8517g2qs9r34bumhc21e
12 May 22
Athira Pharma Reports First Quarter 2022 Financial Results
4:12pm
DEFA14A
4rsjf8939w3 km9wpn
11 Apr 22
Additional proxy soliciting materials
4:36pm
8-K
jnc 8ej67mg6
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
i6o31v
10 Nov 21
Athira Pharma Reports Third Quarter 2021 Financial Results and Business Update
4:11pm
8-K
om6hwox s1
16 Aug 21
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update
4:11pm
8-K
3oqmeiv6
13 May 21
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
4:10pm
8-K
xhqqsriz9 l6nhitb9
25 Mar 21
Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
12:00am
10-K
vwx4a 32qs7f
25 Mar 21
Annual report
12:00am
424B4
62st0w10li
21 Jan 21
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
nv7dtkh
11 Jan 21
Departure of Directors or Certain Officers
6:03am
DRS
p0zq7fb0dsjsxp6c68
6 Jan 21
Draft registration statement
12:00am
10-Q
wm8nupxp5g02k410
12 Nov 20
Quarterly report
4:16pm
8-K
eshd2lz
12 Nov 20
Athira Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights
4:11pm